The updated International League Against Epilepsy definition increases the frequency of epilepsy diagnosis and treatment. In a study of 235 patients with a first seizure, 62.1% were diagnosed with ...

Apr. 15, 2025 — Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global ... Could an Arthritis Drug Unlock Lasting ...

Short-term outcomes for epileptic patients improved following the new International League Against Epilepsy definition and diagnosis criteria. HealthDay News — The new International League ...

Johns Hopkins biomedical engineer Sri Sarma is developing new technologies to pinpoint the exact origin of seizures in the brain—life-changing work for the roughly 21 million epilepsy patients ...

Purple Day 2025: The day is marked by people wearing purple. World Purple Day 2025: World Purple Day is observed annually on March 26 to raise awareness about epilepsy, a neurological disorder ...

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study. Certain common genetic changes might make some people ...

Sebastian Johnston, 21, wants to see more understanding for young people living with epilepsy. He was diagnosed with epilepsy about a year ago, when he had a seizure out of the blue. Leeanne ...

Epilepsy remains one of the most misunderstood neurological disorders, affecting nearly 12 million Indians. While anti-seizure medications are the first line of treatment, about 30% of patients ...

How disturbed signaling pathways could promote epileptic seizures. ScienceDaily . Retrieved April 22, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250416135728.htm ...

The expanded indication was supported by data from a phase 1/2 pharmacokinetics (PK) study (ClinicalTrials.gov Identifier: NCT05076838) that evaluated diazepam nasal spray in pediatric epilepsy ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS ...

Nine months after Johnson & Johnson stepped back from an Addex Therapeutics-partnered epilepsy drug in the wake of a phase 2 fail, the Big Pharma has now fully severed its relationship with the ...